Results 1 to 10 of about 881,201 (350)
To review the cause, epidemiology, pathophysiology, and treatment of cardiogenic shock.A MEDLINE search of the English-language reports published between 1976 and 1998 and a manual search of bibliographies of relevant papers.Experimental, clinical, and basic research studies related to cardiogenic shock.Data in selected articles were reviewed, and ...
Elias Knobel
doaj +6 more sources
Phenotyping Cardiogenic Shock [PDF]
Background Cardiogenic shock (CS) is a heterogeneous syndrome with varied presentations and outcomes. We used a machine learning approach to test the hypothesis that patients with CS have distinct phenotypes at presentation, which are associated with unique clinical profiles and in‐hospital mortality.
Shashank S. Sinha+26 more
openaire +8 more sources
: Cardiogenic shock (CS) is the most common cause of death in hospitalized patients with acute myocardial infarction (AMI). The incidence and mortality of CS in hospitals is also high, although advanced therapy is widely used in CS patients.
hendry purnasidha bagaswoto
doaj +2 more sources
Cardiogenic shock is an acute circulatory failure due to compromised myocardial contractility associated with congenital heart diseases and cardiomyopathies, such as myocarditis. In this article, the authors present a 3-step overview of cardiogenic shock
Sungkyu Cho, Sang-Yun Lee
doaj +3 more sources
Left Ventricular Mechanical Circulatory Support Devices for Cardiogenic Shock After Myocardial Infarction [PDF]
Cardiogenic shock is the most common cause of mortality in patients with acute myocardial infarction (AMI). Historically, AMI complicated by cardiogenic shock was associated with in-hospital survival of only ~50%.
Duc M. Giao, Robert P. Giugliano
doaj +2 more sources
Cardiogenic shock is the second most common cause of circulatory shock, occurs secondary to myocardial infarction, which accounts for 80% of the cases, and remains one of the leading causes of death in patients with acute myocardial infarction ...
Allaqaband, Suhail+2 more
core +4 more sources
Cyrus Vahdatpour+2 more
doaj +6 more sources
BackgroundEarly revascularization of the culprit vessel is the most effective treatment for reducing the risk of mortality from acute STEMI with and without cardiogenic shock.
Jing Wu+6 more
doaj +1 more source
Describing and Classifying Shock: Recent Insights
Cardiogenic shock continues to present a daunting challenge to clinicians, despite an increasing array of percutaneous mechanical circulatory support devices. Mortality for cardiogenic shock has not changed meaningfully in more than 20 years.
Ashleigh Long+3 more
doaj +1 more source